Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors in physiology and pathology
Theodore E. Liston, Sonja Hinz, Christa E. Müller, Deborah Holstein, Jay M. Wendling, Roger J. Melton, Mary E. Campbell, William S. Korinek, R. Rama Suresh, Dane A. Sethre-Hofstad, Zhan-Guo Gao, Dilip K. Tosh, Kenneth A. Jacobson, James D. Lechleiter
Topics & Concepts
ProdrugNucleosideNucleotideBiochemistryIn vivoNucleoside triphosphateAdenosinePharmacologyAgonistChemistryReceptorBiologyBiotechnologyGeneAdenosine and Purinergic SignalingNeurological Complications and SyndromesAdolescent and Pediatric Healthcare